← Open Payments lookup

EMMELINE KATSARELIS: Open Payments

NPI 1013496538 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,825 in 29 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $172 · 2025 $1,825

Food & beverage: $1,735Education: $90
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.16$1,109
AstraZeneca Pharmaceuticals LP6$474
SANOFI-AVENTIS U.S. LLC1$90
GENZYME CORPORATION2$51
HARMONY BIOSCIENCES LLC1$34
Verona Pharma, Inc.1$25
Merck Sharp & Dohme LLC1$22
Lilly USA, LLC1$21

Products named: OFEV, BREZTRI, FASENRA, DUPIXENT, JASCAYD, WAKIX, Ohtuvayre, ZERBAXA.

Industry payments across CA — which companies pay providers there.